There is a growing body of evidence suggesting the upregulation of AFAP1‐AS1, an antisense lncRNA, in various cancer types, including breast cancer,9 cervical cancer,10 pancreatic cancer,11 lung cancer,12 esophageal squamous cell carcinoma.13 Here, AFAP1 is linked to breast carcinoma.